Raltegravir 1200 mg once daily as maintenance therapy in virologically suppressed HIV-1 infected adults: QDISS open-label trial
每日一次服用 1200 毫克拉替拉韦作为病毒学抑制的 HIV-1 感染成人维持治疗:QDISS 开放标签试验
期刊:Aids Research and Therapy
影响因子:2.5
doi:10.1186/s12981-022-00428-5
Hall, Nolwenn; Allavena, Clotilde; Katlama, Christine; Jobert, Alexandra; Molina, Jean-Michel; Cua, Eric; Bani-Sadr, Firouzé; Hocqueloux, Laurent; Duvivier, Claudine; Merrien, Dominique; Hikombo, Hitoto; André-Garnier, Elisabeth; Gaultier, Aurélie; Raffi, François